Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Applied Therapeutics (APLT) Return on Equity (2023 - 2025)

Historic Return on Equity for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 11.41%.

  • Applied Therapeutics' Return on Equity fell 91300.0% to 11.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.41%, marking a year-over-year decrease of 91300.0%. This contributed to the annual value of 5.06% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Applied Therapeutics' Return on Equity is 11.41%, which was down 91300.0% from 4.0% recorded in Q2 2025.
  • Applied Therapeutics' Return on Equity's 5-year high stood at 4.48% during Q4 2023, with a 5-year trough of 11.41% in Q3 2025.
  • Over the past 3 years, Applied Therapeutics' median Return on Equity value was 2.6% (recorded in 2024), while the average stood at 2.83%.
  • The largest annual percentage gain for Applied Therapeutics' Return on Equity in the last 5 years was 6700bps (2025), contrasted with its biggest fall of -91300bps (2025).
  • Over the past 3 years, Applied Therapeutics' Return on Equity (Quarter) stood at 4.48% in 2023, then crashed by -171bps to 3.2% in 2024, then plummeted by -256bps to 11.41% in 2025.
  • Its Return on Equity was 11.41% in Q3 2025, compared to 4.0% in Q2 2025 and 2.25% in Q1 2025.